Q. What is your testing process for my organization?
Our testing system is optimized to minimize downtime and disruptions for your organization. Our team will work with you to customize a testing response plan, deploy a team of medics, test your team, and provide test results with a rapid turnaround.
Q. How rapidly can your team deploy to our location?
We can typically deploy a team within 48-72 hours.
Q. What technology are you using to conduct the test?
The backbone of our testing program utilizes a validated real-time Reverse Transcriptase PCR (rRT-PCR) assay for the specific detection of the SARS-CoV-2 virus.
Q. Where are you performing the tests?
Our molecular testing is performed in registered CLIA laboratories using the latest molecular science technologies.
Q. What sample methods can be used?
The process has been validated for nasal swabs and sputum/saliva samples for COVID-19 testing. Most sampling is done using swabs.
Q. What is the accuracy of the test?
The molecular testing assay we are utilizing have been found to exceed the minimum recommendations provided by FDA policies and have been determined to be >95% specific, sensitive, and accurate.
Q. What are the approvals on this test?
This test is provided under the FDA’s Emergency Use Authorization (EUA) process.
Q: What is your turnaround time?
Total turnaround time from sampling, transportation to the lab and testing is approximately 48 hours or less. Exact timing is determined by a variety of factors and can be optimized for your location and specific requirements.